Garrett N, Norman E, Leask K, Naicker N, Asari V, Majola N, Abdool Karim Q, and Abdool Karim SS.
AIDS and Behavior 2018; 22(3):1018-1024.
Vandormael A, Bärnighausen T, Herbeck J, Tomita A, Phillips A, Pillay D, de Oliveira T, Tanser F.
Clinical Infectious Diseases 2018; 66(8):1254-1260.
Dawood H, Hassan-Moosa R, Yende-Zuma N, Naidoo K.
BMC Infectious Diseases 2018; 18(1):168. doi: 10.1186/s12879-018-3083-z.
Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim SS, Moore PL, Ackerman ME, Alter G, Morris L.
PLoS Pathogens 2018; 14(4): e1006987. doi: 10.1371/journal.ppat.1006987.
Humphries H, Osman F, Knight L, Abdool Karim Q.
PLoS One 2018; 13(4): e0195107. doi: 10.1371/journal.pone.0195107
Smith CM, Lessells R, Grant AD, Herbst K, Tanser F.
International Union against Tuberculosis and Lung Disease 2018; 22(3):287-293.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.